Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 54903 vs Fluticasone in Asthma
NCT01397201Phase 2Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2011
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of olodaterol in asthma, sponsored by Boehringer Ingelheim. Started Jul 2011; status: terminated.
02
Drugs
olodaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01397201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01397201.